Early-stage Development, Xcelodose & Clinical Phases

Sep 21, 2017

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the same time as there are major changes happening in the research and development of highvalue and often potent ...

Read More

Driving by Data: A Faster, Better Road to Market

Sep 21, 2017

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge at PAREXEL International explain that, while there is no single transformative solution to streamline clinical ...

Read More

Enrolment Compliance and Study Data

Sep 21, 2017

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, Tatiana Dumpis, Alexey Maximovich, John Riefler and Maxim Belotserkovskiy, at PSI-CRO, discuss how the eligibility ...

Read More